{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:32:24Z","timestamp":1761863544143,"version":"build-2065373602"},"reference-count":0,"publisher":"Canadian Society of Healthcare-Systems Pharmacy","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Can J Hosp Pharm"],"abstract":"<jats:p>Background: Canadians face unprecedented substance-related harms, affecting their health, livelihoods, and relationships. While medications are commonly used for withdrawal, harm reduction, and treatment, the role of pharmacists in addiction medicine care settings remains unclear.\nObjective: To explore the roles, activities, facilitators, barriers, and value added of pharmacists working in the area of substance use disorder in Canada\u2019s publicly funded health care systems.\nMethods: This qualitative study was based on virtual interviews conducted from January 26 to February 14, 2024, with 15 pharmacists practising in Canada. Participants were included if they provided direct patient care within a publicly funded system with a component of their focus in addiction medicine. Interviews were transcribed and analyzed using NVivo 12 software, and thematic analysis was employed to identify key themes. Narratives were developed to demonstrate the wide variety of workplaces, roles, and responsibilities of the participants.\nResults: The 15 participating pharmacists, from 7 provinces, described diverse activities, including provision of education, gathering of information, assessment, prescribing and administration of medications, harm reduction, support of care transitions, policy development, and strengthening of therapeutic alliances. Areas of focus included being surprised by working in \u201cgrey\u201d areas, experiencing barriers relating to the scope of their positions, and adding value by having specialized knowledge about medications.\nConclusions: Pharmacists in Canada play diverse roles in substance use disorder care, with the potential to expand system capacity and improve medication management. However, systemic support and innovation are needed to encourage their increased involvement, and further research is needed to evaluate outcomes associated with implementation of these roles.\nKeywords: hospital pharmacy services, addiction medicine, substance use disorder, primary care, ambulatory care, pharmacist\nR\u00c9SUM\u00c9\nContexte : Les Canadiens sont confront\u00e9s \u00e0 des m\u00e9faits sans pr\u00e9c\u00e9dent li\u00e9s aux substances, qui affectent leur sant\u00e9, leurs moyens de subsistance et leurs relations. Bien que des m\u00e9dicaments soient couramment utilis\u00e9s pour le sevrage, la r\u00e9duction des m\u00e9faits et le traitement, le r\u00f4le des pharmaciens dans le domaine des soins en m\u00e9decine des d\u00e9pendances demeure flou.\nObjectif : Examiner les r\u00f4les, les activit\u00e9s, les facilitateurs, les obstacles et la valeur ajout\u00e9e des pharmaciens travaillant dans le domaine des troubles li\u00e9s \u00e0 l\u2019usage de substances au sein des syst\u00e8mes de sant\u00e9 financ\u00e9s par les deniers publics.\nM\u00e9thodologie : Cette \u00e9tude qualitative se basait sur des entretiens virtuels r\u00e9alis\u00e9s du 26 janvier au 14 f\u00e9vrier 2024 avec 15 pharmaciens pratiquant au Canada. Les participants \u00e9taient inclus s\u2019ils prodiguaient des soins directs aux patients au sein d\u2019un syst\u00e8me financ\u00e9 par l\u2019\u00c9tat, avec un aspect de leur pratique ax\u00e9 sur la m\u00e9decine des d\u00e9pendances. Les entretiens ont \u00e9t\u00e9 transcrits et analys\u00e9s \u00e0 l\u2019aide du logiciel NVivo 12, et une analyse th\u00e9matique a \u00e9t\u00e9 employ\u00e9e pour identifier les th\u00e8mes cl\u00e9s. Des sc\u00e9narios ont \u00e9t\u00e9 \u00e9labor\u00e9s pour illustrer la grande diversit\u00e9 des lieux de travail, des r\u00f4les et des responsabilit\u00e9s des participants.\nR\u00e9sultats : Les 15 pharmaciens qui ont particip\u00e9 \u00e0 l\u2019\u00e9tude, en provenance de 7 provinces, ont r\u00e9v\u00e9l\u00e9 une diversit\u00e9 d\u2019activit\u00e9s, notamment la sensibilisation des patients, la collecte d\u2019informations, l\u2019\u00e9valuation, la prescription et l\u2019administration de m\u00e9dicaments, la r\u00e9duction des risques, le soutien pour les transitions de soins, l\u2019\u00e9laboration de politiques et le renforcement des alliances th\u00e9rapeutiques. Les domaines d\u2019int\u00e9r\u00eat comprenaient le fait d\u2019\u00eatre surpris de travailler dans des zones \u00ab floues \u00bb, l\u2019exp\u00e9rience d\u2019obstacles li\u00e9s \u00e0 la port\u00e9e de leurs fonctions, et la valeur ajout\u00e9e associ\u00e9e \u00e0 la d\u00e9tention de connaissances sp\u00e9cialis\u00e9es sur les m\u00e9dicaments.\nConclusions : Les pharmaciens au Canada jouent divers r\u00f4les dans les soins li\u00e9s aux troubles de l\u2019usage de substances, avec un potentiel d\u2019\u00e9largir la capacit\u00e9 du syst\u00e8me et d\u2019am\u00e9liorer la gestion de la m\u00e9dication. Cependant, le soutien syst\u00e9mique et l\u2019innovation sont n\u00e9cessaires pour encourager une plus grande implication, et des recherches suppl\u00e9mentaires sont requises pour \u00e9valuer les r\u00e9sultats associ\u00e9s \u00e0 la mise en \u0153uvre de ces r\u00f4les.\nMots-cl\u00e9s : services des pharmacies d\u2019h\u00f4pitaux, m\u00e9decine des d\u00e9pendances, trouble li\u00e9 \u00e0 l\u2019usage de substances, soins primaires, soins ambulatoires, pharmacien<\/jats:p>","DOI":"10.4212\/cjhp.3680","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T16:09:15Z","timestamp":1747238955000},"source":"Crossref","is-referenced-by-count":0,"title":["Role of Pharmacists in Addiction Medicine in Canada\u2019s Publicly Funded Health Care Systems: A Qualitative Study"],"prefix":"10.4212","volume":"78","author":[{"given":"Amy","family":"Wiebe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Pecson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maggie","family":"Coupland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katelyn","family":"Halpape","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2732","published-online":{"date-parts":[[2025,5,14]]},"container-title":["Canadian Journal of Hospital Pharmacy"],"original-title":[],"link":[{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3680\/5617","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3680\/5618","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/download\/3680\/5617","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,8]],"date-time":"2025-07-08T14:41:00Z","timestamp":1751985660000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cjhp-online.ca\/index.php\/cjhp\/article\/view\/3680"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,14]]},"references-count":0,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,4,9]]}},"URL":"https:\/\/doi.org\/10.4212\/cjhp.3680","relation":{},"ISSN":["1920-2903","0008-4123"],"issn-type":[{"type":"electronic","value":"1920-2903"},{"type":"print","value":"0008-4123"}],"subject":[],"published":{"date-parts":[[2025,5,14]]},"article-number":"e3680"}}